Center for Scientific Review; Notice of Closed Meetings, 69501-69502 [2014-27561]

Download as PDF 69501 Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices • The collections are low-burden for respondents (based on considerations of total burden hours, total number of respondents, or burden-hours per respondent) and are low-cost for both the respondents and the Federal Government; • The collections are noncontroversial and do not raise issues of concern to other Federal agencies; • Any collection is targeted to the solicitation of opinions from respondents who have experience with the program or may have experience with the program in the near future; • Personally identifiable information (PII) is collected only to the extent necessary and is not retained; • Information gathered will be used only internally for general service improvement and program management purposes and is not intended for release outside of the agency; • Information gathered will not be used for the purpose of substantially informing influential policy decisions; and • Information gathered will yield qualitative information; the collections will not be designed or expected to yield statistically reliable results or used as though the results are generalizable to the population of study. Feedback collected under this generic clearance provides useful information, but it does not yield data that can be generalized to the overall population. This type of generic clearance for qualitative information will not be used for quantitative information collections that are designed to yield reliably actionable results, such as monitoring of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid Office of Management and Budget control number. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 4,358. trends over time or documenting program performance. Such data uses require more rigorous designs that address: The target population to which generalizations will be made, the sampling frame, the sample design (including stratification and clustering), the precision requirements or power calculations that justify the proposed sample size, the expected response rate, methods for assessing potential nonresponse bias, the protocols for data collection, and any testing procedures that were or will be undertaken prior to fielding the study. Depending on the degree of influence the results are likely to have, such collections may still be eligible for submission for other generic mechanisms that are designed to yield quantitative results. As a general matter, information collections will not result in any new system of records containing privacy information and will not ask questions of a sensitive nature, such as sexual behavior and attitudes, religious beliefs, and other matters that are commonly considered private. Request for Comments: Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval. Comments are invited on: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity Estimated Annualized Burden Hours ESTIMATED ANNUAL REPORTING BURDEN Number of respondents Type of collection Annual frequency per response Hours per response Total hours Customer Satisfaction Surveys ....................................................................... In-Depth Interviews (IDIs) or Small Discussion Groups .................................. Focus Groups .................................................................................................. Usability and Pilot Testing ............................................................................... Conference/Training—Pre and Post Surveys ................................................. 1,000 1,000 1,000 150,000 100,000 1 1 1 1 2 30/60 90/60 90/60 5/60 10/60 500 1,500 1,500 12,525 33,333 Total .......................................................................................................... ........................ ........................ ........................ 49,358 mstockstill on DSK4VPTVN1PROD with NOTICES Dated: November 13, 2014. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2014–27637 Filed 11–20–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. VerDate Sep<11>2014 18:00 Nov 20, 2014 Jkt 235001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\21NON1.SGM 21NON1 69502 Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Neuropharmacology. Date: December 12, 2014. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard D. Crosland, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, 301–435– 1220, crosland@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Neuropsychiatric Mechanisms. Date: December 12, 2014. Time: 12:30 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Deborah L. Lewis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD 20892, 301–408– 9129, lewisdeb@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: November 17, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–27561 Filed 11–20–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services [CIS No. 2551–14; DHS Docket No. USCIS– 2014–0011] RIN 1615–ZB33 Designation of Liberia for Temporary Protected Status U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: Notice. mstockstill on DSK4VPTVN1PROD with NOTICES AGENCY: Through this Notice, the Department of Homeland Security (DHS) announces that the Secretary of Homeland Security (Secretary) has designated Liberia for Temporary Protected Status (TPS) for a period of 18 SUMMARY: VerDate Sep<11>2014 18:00 Nov 20, 2014 Jkt 235001 months, effective November 21, 2014 through May 21, 2016. Under section 244(b)(1)(C) of the Immigration and Nationality Act (INA), 8 U.S.C. 1254a(b)(1)(C), the Secretary is authorized to designate a foreign state (or any part thereof) for TPS upon finding that the foreign state is experiencing extraordinary and temporary conditions that prevent its nationals from returning in safety and that permitting such aliens to remain temporarily in the United States is not contrary to the national interest. This designation allows eligible Liberian nationals (and aliens having no nationality who last habitually resided in Liberia) who have continuously resided in the United States since November 20, 2014 and been continuously physically present in the United States since November 21, 2014 to be granted TPS. This Notice also describes the other eligibility criteria applicants must meet. Individuals who believe they may qualify for TPS under this designation may apply within the 180-day registration period that begins on November 21, 2014 and ends on May 20, 2015. They may also apply for Employment Authorization Documents (EADs) and for travel authorization. Through this Notice, DHS also sets forth the procedures for nationals of Liberia (or aliens having no nationality who last habitually resided in Liberia) to apply for TPS, EADs, and travel authorization with U.S. Citizenship and Immigration Services (USCIS). Given the Ebola Virus Disease (EVD)related basis for the designations of Liberia, Guinea, and Sierra Leone for TPS and ongoing efforts to prevent the spread of EVD, requests for advance travel authorization (‘‘advance parole’’) for travel to one or more of these three countries will not be approved, as a matter of discretion, absent extraordinary circumstances. If you depart from the United States without obtaining advance parole or you do not comply with any conditions that may be placed on your advance parole document, you may not be permitted to re-enter the United States. TPS beneficiaries who are granted advance parole to travel to Liberia, Guinea or Sierra Leone are advised that they, like other aliens granted advance parole, are not guaranteed parole into the United States. A separate decision regarding your ability to enter will be made when you arrive at a port-of-entry upon your return. Individuals considering travel outside the United States should visit the Department of State’s Web site for the most up-to-date information in PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 Travel Alerts and Warnings and in the Ebola Fact Sheet for Travelers. DATES: This designation of Liberia for TPS is effective on November 21, 2014 and will remain in effect through May 21, 2016. The 180-day registration period for eligible individuals to submit TPS applications begins November 21, 2014, and will remain in effect through May 20, 2015. FOR FURTHER INFORMATION CONTACT: • For further information on TPS, including guidance on the application process and additional information on eligibility, please visit the USCIS TPS Web page at http://www.uscis.gov/tps. You can find specific information about this designation of Liberia for TPS by selecting ‘‘TPS Designated Country: Liberia’’ from the menu on the left of the TPS Web page. • You can also contact the TPS Operations Program Manager at the Family and Status Branch, Service Center Operations Directorate, U.S. Citizenship and Immigration Services, Department of Homeland Security, 20 Massachusetts Avenue NW., Washington, DC 20529–2060; or by phone at (202) 272–1533 (this is not a toll-free number). Note: The phone number provided here is solely for questions regarding this TPS Notice. It is not for individual case status inquires. • Applicants seeking information about the status of their individual cases can check Case Status Online, available at the USCIS Web site at http:// www.uscis.gov, or call the USCIS National Customer Service Center at 800–375–5283 (TTY 800–767–1833). Service is available in English and Spanish. • Further information will also be available at local USCIS offices upon publication of this Notice. SUPPLEMENTARY INFORMATION: Table of Abbreviations BIA—Board of Immigration Appeals DHS—Department of Homeland Security DOS—Department of State EAD—Employment Authorization Document EVD—Ebola Virus Disease FNC—Final Nonconfirmation IJ—Immigration Judge INA—Immigration and Nationality Act OSC—U.S. Department of Justice, Office of Special Counsel for Immigration-Related Unfair Employment Practices SAVE—USCIS Systematic Alien Verification for Entitlements Program Secretary—Secretary of Homeland Security TNC—Tentative Nonconfirmation TPS—Temporary Protected Status TTY—Text Telephone USCIS—U.S. Citizenship and Immigration Services WHO—World Health Organization E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 79, Number 225 (Friday, November 21, 2014)]
[Notices]
[Pages 69501-69502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-27561]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 69502]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Neuropharmacology.
    Date: December 12, 2014.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Richard D. Crosland, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 
20892, 301-435-1220, crosland@nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Neuropsychiatric Mechanisms.
    Date: December 12, 2014.
    Time: 12:30 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Deborah L. Lewis, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD 
20892, 301-408-9129, lewisdeb@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS).

    Dated: November 17, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-27561 Filed 11-20-14; 8:45 am]
BILLING CODE 4140-01-P